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a b s t r a c t
The lack of efﬁcient refolding methodologies must be overcome to take full advantage of the fact that
bacteria express high levels of aggregated recombinant proteins. High hydrostatic pressure (HHP) impairs
intermolecular hydrophobic and electrostatic interactions, dissociating aggregates, which makes HHP a
useful tool to solubilize proteins for subsequent refolding. A process of refolding was set up by using
as a model TsnC, a thioredoxin that catalyzes the disulﬁde reduction to a dithiol, a useful indication of
biological activity. The inclusion bodies (IB) were dissociated at 2.4 kbar. The effect of incubation of IB
suspensions at 1–800 bar, the guanidine hydrochloride concentration, the oxidized/reduced glutathione
(GSH/GSSG) ratios, and the additives in the refolding buffer were analyzed. To assess the yields of fully
biologically active protein obtained for each tested condition, it was crucial to analyze both the TsnC sol-
ubilization yield and its enzymatic activity. Application of 2.4 kbar to the IB suspension in the presence of
9 mM GSH, 1 mM GSSG, 0.75 M guanidine hydrochloride, and 0.5 M arginine with subsequent incubation
at 1 bar furnished high refolding yield (81%). The experience gained in this study shall help to establish
efﬁcient HHP-based protein refolding processes for other proteins.
 2014 Elsevier Inc. All rights reserved.
Introduction
To obtain biomedically relevant proteins that occur at low
concentrations in their native sources, researchers have expressed
recombinant proteins in Escherichia coli, the bacterial species that
is most often employed to produce heterologous proteins for
structural and functional studies and to obtain commercially
valuable proteins.
Hydrophobic interactions among misfolded molecules
determine aggregation and inclusion body (IB) formation. Soluble
recombinant proteins are occasionally expressed, especially when
the transformed bacteria are cultivated at low temperature.
Expression of recombinant proteins in E. coli as a soluble state in
the cytoplasm is preferred as a norm, because these compounds
usually acquire a native state without the need for further refold-
ing processing. Nevertheless, a number of recombinant proteins
may aggregate even if the host is cultivated at low temperature.
In this condition, IB with higher degree of intramolecular interac-
tions emerges at the cost of intermolecular contacts and generates
proteins with secondary structures that resemble the correspond-
ing native state more closely than when the bacteria is grown at
higher temperatures [1,2]. For subsequent refolding, it is interest-
ing that the IB displays a network of intermolecular contacts that
is easy to break, to facilitate protein solubilization at relatively
mild conditions while preserving the IB native-like existing
structures [3]. The expression of proteins as aggregates offers
important advantages over their production in the soluble form.
First, their expression level is generally high. Second, it is possible
to physically remove the undesirable host contaminants from the
insoluble aggregates, to increase the purity of the target protein.
Unfortunately, establishing a simple and efﬁcient protocol for
protein refolding from the IB remains a difﬁcult challenge [4].
High hydrostatic pressure (HHP)1 has been widely used to
study protein conformation. Application of 1–3 kbar disrupts the
http://dx.doi.org/10.1016/j.pep.2014.10.013
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intermolecular electrostatic and hydrophobic interactions, dissoci-
ating oligomeric and aggregated proteins. The same kind of inter-
actions that maintain the aggregated states also preserve the
secondary and tertiary protein structures in their native confor-
mation [5–7]. However, more efﬁcient protein hydration followed
by disruption of intramolecular bonds and subsequent protein
denaturation generally requires pressure higher than 4 and 5 kbar
[8]. Therefore, the use of 2–3 kbar constitutes a non-denaturing
technique that solubilizes aggregates and keeps the secondary
and tertiary protein structure intact, being potentially applicable
in protein refolding [9,10]. In this context, HHP has become a
technique to obtain high-yield protein refolding [11–14]. Quanti-
ﬁcation of the target protein in the soluble fraction often aids
determination of the refolding process efﬁciency [15,16]. Never-
theless, the fact that a protein is soluble does not necessarily
imply that it is in the native conformation, with full biological
activity. Therefore, it can be important to determine both the
degree of solubilization as well as the biological activity of the
target protein during optimization of the refolding process.
Thioredoxin are enzymes that play key roles in cell biology,
among them as hydrogen donors for the reduction of ribonucleo-
tides to deoxyribonucleotides (building blocks of DNA) [17]; and
as substrates for peroxiredoxin, the most relevant cellular
pathway for removal of hydroperoxides [18]. Thioredoxins are
thiol-disulﬁde oxido-reductases of about 12 kDa; they display a
Trp-Cys-Gly-Pro-Cys motif that reversibly switches between the
disulﬁde and dithiol states. Dithiol thioredoxin can reduce
proteins such as ribonucleotide reductase and peroxiredoxin, to
generate disulﬁde thioredoxin. NADPH then reduces the enzyme
in its disulﬁde form in a reaction catalyzed by thioredoxin reduc-
tase, a ﬂavo-enzyme [17,19].
This work employed TsnC, a thioredoxin from Xylella fastidiosa,
in refolding studies. X. fastidiosa is an economically important
gram-negative bacterium: it is the causative agent of variegated
chlorosis disease (CVC) in Brazil and of Pierce’s disease (grapes)
and oleander leaf scorch in southern United States [20]. TsnC dis-
plays the characteristic features of thioredoxins such as lowmolec-
ular weight and the Trp-Cys-Gly-Pro-Cys motif in the active site.
Remarkably, TsnC can reduce peroxiredoxin PrxQ [21] but not
Ohr [22], two Cys-based, thiol-dependent peroxidases from X. fasti-
diosa. Because the enzymatic assay for TsnC is well established, this
protein is suitable for application in refolding studies that consider
not only solubility, but also activity for optimization purposes.
More speciﬁcally, the present study describes the refolding of IB
aggregates of the thioredoxin TsnC from X. fastidiosa produced in
E. coli. The aggregates were dissociated at 2.4 kbar. The refolding
conditions were optimized with respect to the reduced glutathione
(GSH)/oxidized glutathione (GSSG) ratio, the guanidine hydrochlo-
ride concentration, and the presence of additives. TsnC quantiﬁca-
tion in the soluble fraction and activity determination by the
thioredoxin activity assay aided analysis of the refolding process
efﬁciency. The best TsnC refolding yield was 81%: each liter of bac-
terial culture (2.5 g wet cells) afforded 55 mg of biologically active
TsnC.
Materials and methods
TsnC expression, growth conditions, cell fractionation, and IB isolation
To express recombinant TsnC, in this work a BL21(DE3) E. coli
strain was transformed with the vector pET15b containing the
TsnC gene cloned into the EcoRI/Hind III restriction sites [21,22].
A colony was randomly picked from transformants that were
grown on LB plates (10 g L1 tryptone, 5 g L1 yeast extract,
10 g L1 NaCl) containing 100 lg mL1 ampicillin and inoculated
in 0.5 L of 2-HKSII rich medium [23]. Cells were grown at 37 C,
and expression was induced by addition of isopropyl–D-thiogalac-
topyranoside (0.5 mM) when the absorbance at 600 nm reached
approximately 3.0. After incubation with constant orbital agitation
(150 rpm) for 16 h, the bacteria were collected by centrifugation at
5000g at 4 C, for 10 min. The pellet containing approximately 1.2 g
of wet cells was resuspended in 50 mL of 100 mM Tris–HCl, pH 8.0,
and 5 mM EDTA. Lysozyme at a ﬁnal concentration of 50 lg mL1
was added to the suspension, which was followed by incubation
at room temperature for 15 min. The suspension was sonicated
in the presence of 0.1% sodium deoxycholate and centrifuged at
8600g for 10 min. The supernatant was discarded, and the pellet
was suspended in 50 mL of 100 mM Tris–HCl, pH 8.0, with 5 mM
EDTA and 0.1% sodium deoxycholate. The pellet was washed twice
in 50 mL 50 mM Tris–HCl, pH 8.0; suspended in 10 mL of the same
buffer; distributed in aliquots; and stored at 20 C.
Soluble and bioactive TsnC was used as the positive control in
the solubilization protocols and, as thioredoxin reductase (TrxR),
was obtained as described below. ADA94(DE3) E. coli transformed
with pET-15b/TsnC or pET-15b/TrxR were cultured overnight in
50 mL LB medium containing ampicillin (100 lg mL1). Each
culture was then transferred to 1 L of fresh LB plus antibiotics
and grown until the OD600nm reached 0.6–0.8. Afterwards, IPTG
(0.5 mM) was added to the culture, and the cells were grown over-
night at 20 C, followed by harvesting via centrifugation and stored
at 20 C. Frozen cells were suspended in 20 mL buffer (20 mM
sodium phosphate buffer pH 7.4, 0.5 M sodium chloride, 20 mM
imidazole) and disrupted by sonication. Cell extracts were kept
on ice during 1% streptomycin sulfate treatment for 20 min. The
suspension was centrifuged at 16,000g for 40 min to remove
nucleic acid precipitates and cell debris. Finally, the soluble frac-
tion was applied to a nickel afﬁnity column (Hi-Trap from GE
Healthcare) and the conditions of His-tagged protein puriﬁcation
were optimized according to the manufacturer’s instructions.
[21]. The recombinant proteins were quantiﬁed by A280 through
in silico prediction of extinction coefﬁcients (ExPASy; available on
the World Wide Web).
Sample compression
The IB suspensions were diluted in 1 mL of refolding buffer
(50 mM Tris–HCl, pH 8.0, 1 mM EDTA) in the presence of the
additives NaCl (0.15 M), L-arginine (0.5 M) or L-arginine HCl
(0.5 M), glucose (1 M), sucrose (1 M), PEG 6000 (0.1%), glycerol
(2.5 M), Tween 20 (1 mM), Triton X-100 (0.5 mM) or in the absence
of additives, as indicated in the ﬁgures. The diluted IB suspensions
were placed into plastic bags that were subsequently sealed and
then placed in another larger vacuum/heat-sealed plastic bag.
The bags were placed in a pressure vessel (R4-6-40, High-Pressure
Equipment), and oil was used as a pressure-transmitting ﬂuid.
After decompression, the samples were centrifuged at 12,000g
for 15 min. The supernatants were dialyzed to remove GdnHCl,
arginine GSH/GSSG and other additives and centrifuged again.
The pellets were discarded, and the soluble fractions were stored
at 20 C for subsequent analysis.
Determination of the percentage of solubilized TsnC
SDS–PAGE analysis was performed on 15% SDS–polyacrylamide
gels. Equivalent volumes of untreated IB suspensions or of soluble
fractions of the HHP-treated suspensions containing the same
original amount of IB were heated in SDS–PAGE sample buffer
(50 mM Tris–HCl, pH 8.5 containing 2% SDS, 1% dithiothreitol,
0.01% bromophenol blue, and 10% glycerol) at 95 C for 5 min
and were applied on SDS–PAGE. The gels were and stained with
Coomassie Blue G-250. Image J software (http://www.ncbi.nlm.
nih.gov) was used to analyze the bands that emerged in digital
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photographs of the gels, to determine the percentage of soluble
TsnC in HHP-treated samples as compared with the total amount
of TsnC originally present in IB.
Circular dichroism
CD spectra were recorded on a Jasco-J810 spectropolarimeter
equipped with a temperature-controlled liquid system, using an
optical cuvette with a light path of 0.1 cm. TsnC was analyzed at
a concentration of 18.2 lM. The reported ellipticity curves
correspond to the average of ﬁve measurements collected over
5 min. The measurements were conducted at 20 C.
Determination of the enzymatic activity of the thioredoxin TsnC
Thioredoxin activity was assayed on the basis of its ability to
catalyze the reduction of the artiﬁcial disulﬁde 5,50-dithiobis(2-
nitrobenzoic acid) (DTNB) to 2-nitro-5-thiobenzoic acid (TNB), as
previously described [22]. Brieﬂy, the protein TsnC refolded at
HHP at concentrations of 1, 0.75, 0.5 or 0.25 lM were incubated
with 200 lM b-nicotinamide adenine dinucleotide 20-phosphate
reduced (NADPH), 1 lM thioredoxin reductase (TrxR), and
100 lMDTPA in 20 mM Tris–HCl, pH 8.0, in a 96-well plate, to give
a total reaction volume of 370 lL. The reaction was initiated by
addition of DTNB (500 lM) at 37 C; TNB production was
monitored in a plate reader at a wavelength of 412 nm
(e = 14150 M1 cm1) [24]. A sample containing no TrxR was used
as negative control.
Scanning electron microscopy
Scanning electron microscopy was performed by drying the
water-dialyzed insoluble IB onto clean polished Philips stubs,
followed by sputter coating in a SCD-040 sputter coater (Balzer)
at 38 mA, for 120 s. The samples were then viewed and photo-
graphed using a Philips XL-200 scanning electron microscope.
Results and discussion
TsnC expression
In the present study, we expressed the X. fastidiosa TsnC gene,
which generated a product containing an N-terminal Histidine
tag with a molecular weight of 14.7 kDa. At 20 C, we were only
able to express TsnC at low levels, mainly in the soluble fraction
(Fig. 1). At higher temperature, this protein chieﬂy emerged as
higher levels of insoluble aggregates (Fig. 1). Important advantages
of using the TsnC produced at 37 C and in the insoluble fraction is
the lower level of contamination by bacterial proteins and higher
expression levels. To produce the protein for the subsequent
assays, we decided to induce bacterial expression of TsnC at the
temperature that furnished the highest level of insoluble TsnC
(37 C).
Effect of disulﬁde-shufﬂing reagents on TsnC refolding
HHP cannot cleave the disulﬁde intermolecular covalent cross-
links of protein aggregates. In the case of polypeptides containing
disulﬁde bonds, it can be necessary to add an oxidant-reducer pair
to the refolding solution. This should disrupt the intermolecular
disulﬁde bonds and trigger a cycle of reduction and oxidation
steps, generating the disulﬁde bonds of the native conformation.
Low free energy should stabilize these bonds [16]. Because TsnC
contains two Cys residues (C33–C36), we initially optimized the
redox conditions of the refolding buffer by compressing the TsnC
IB suspensions at 2.4 kbar for 16 h in the presence of different
GSH/GSSG ratios. After decompression, a dialyzation was
performed to withdraw the reagents GSH, GSSH and GdnHCl before
performing the quantiﬁcation of TsnC in the soluble fraction and of
its enzymatic activity. Compression of the IB suspension afforded
soluble TsnC in 60–80% yield (Fig. 2A). However, TsnC presented
up to 6.6-fold higher activity upon refolding at GSH/GSSG ratios
equal to or higher than 1 (Fig. 2B), suggesting that refolding of TsnC
was more efﬁcient in the reduced rather than in the oxidized state.
The results also showed that determining the biological activity of
the soluble recombinant protein could be critical when establish-
ing the optimal refolding conditions. This approach allow the iden-
tiﬁcation of a protocol that eliminates the chance to select a
Fig. 1. TsnC (14.7 kDa) production in E. coli cultivated in rich medium (2HK2) at
different temperatures, after activation. S: soluble fraction of bacteria; I: insoluble
fraction of bacteria.
Fig. 2. The GSH/GSSG ratio affects TsnC solubilization and enzymatic activity of the
product obtained by HHP treatment of IB suspensions. (A) Percentage of soluble
TsnC as determined by SDS–PAGE in relation to the bands corresponding to TsnC
in IB suspensions used as a 100% TsnC; (B) thioredoxin activity of 1 lM TsnC.
Refolding buffer: 50 mM Tris–HCl, pH 8.0, 1 mM EDTA, and 1.5 M GdnHCl. The
samples were pressurized in buffer containing a ﬁnal concentration of 10 mM
glutathione (GSH + GSSG) at the proportions depicted in the X-axis, at a 2.4-kbar
compression for 16 h. The supernatants were subjected to dialysis. Control (0:0)
was performed in the absence of GSH/GSSG.
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condition that favors the formation of a soluble but without enzy-
matic activity, therefore probably in a misfolded state. Therefore,
we conducted subsequent assays at 9 GSH:1 GSSG.
Effect of GdnHCl on TsnC refolding
The establishment of non-native intermolecular hydrogen
bonds in the aggregates interferes with pressure-induced dissolu-
tion, because these bonds are insensitive to pressure. On the other
hand, chaotropic agents such as urea or GdnHCl can help to break
these bonds, dissolving the insoluble aggregates [25]. Due to the
fact that HHP favor the dissociation of aggregates, lower concentra-
tion of GdnHCl than that usually used for solubilization of IB at
atmospheric pressure is usually required. Concentrations of
GdnHCl from 0.5 to 6 M promoted 27–47% IB dissociation
(Fig. 3A). GdnHCl at 0.75 M provided the maximum enzymatic
activity (Fig. 3B). The lower yield of soluble TsnC at high GdnHCl
concentration (6 M) probably stemmed from larger exposure of
the TsnC hydrophobic domains, which re-aggregated during dialy-
sis. On the basis of the data described in Fig. 3A and B, we used
0.75 M GdnHCl for the subsequent assays.
Effect of incubation at different pressure levels on TsnC refolding
The literature suggests that compression of aggregated proteins
at high pressure (2–3 kbar) induces dissociation and refolding
[10,26]. However, there are also articles in the literature that
indicate that protein folding occurs during incubation at lower
pressure levels (0.3–0.7 kbar) [13,27] or at atmospheric pressure
[9]. To determine the conditions that favor TsnC refolding, IB sus-
pensions were subjected to incubation at 2.4 kbar for 16 h. As
alternative conditions, the IB suspensions were compressed at
2.4 kbar for 90 min for dissociation of the aggregates, which was
followed by decompression to 0.8, 0.4, 0.2 kbar or 1 bar for refold-
ing, condition that was maintained for 16 h before complete
decompression and dialysis. Refolding of TsnC occurs preferentially
at low pressure, as shown by the highest level of soluble protein
with enzymatic activity that was found when the protein was incu-
bated for 16 h at atmospheric pressure. Therefore, we chose the
following conditions for refolding: incubation at 2.4 kbar for
90 min, followed by incubation at 1 bar for 16 h.
Effect of the presence of additives on TsnC refolding
A frequent problem encountered during protein refolding is re-
aggregation due to intermolecular interaction between the
exposed hydrophobic domains. To raise the refolding yields, it is
common to use additives – they create an environment where
the refolding rate increases, the aggregation rate decreases, and
the native folded protein becomes stable instead of undergoing a
transition to intermediate states. The presence of low-molecular-
weight compounds (sugars, polyols, and hydrophilic polymers)
enhances protein stability during refolding: they slow down the
unfolding step or reduce the concentration of aggregation-prone
species, improving the refolding yields. Unfavorable interactions
between these additives and protein surfaces underlie such
stabilizing effects. These interactions preferentially exclude the
additives and reduce the protein surface exposed to the solvent
[28–30]. However, because such stabilizers can enhance aggrega-
tion, they have been used in combination with aggregation inhib-
itors that, in opposition, are preferentially bound to the protein and
augment the protein surface exposed to the solvent [31]. The
mechanism through which arginine inhibits aggregation has not
Fig. 3. GdnHCl concentration affects TsnC solubilization and enzymatic activity of
the product obtained by HHP treatment of IB suspensions. (A) percentages of
soluble TsnC as determined by SDS–PAGE in relation to the bands of the IB
suspensions used as a 100% TsnC; (B) thioredoxin activity of 1 lM TsnC. Refolding
buffer: 50 mM Tris–HCl, pH 8.0, 1 mM EDTA. The samples were pressurized in
buffer containing a ﬁnal concentration of 10 mM redox pair (9 mM GSH and 1 mM
GSSG) at 2.4 kbar for 16 h. The supernatants were subjected to dialysis.
Fig. 4. Additives affect TsnC solubilization and enzymatic activity of the product
obtained by HHP treatment of IB suspensions. (A) Percentages of soluble TsnC as
determined by SDS–PAGE in relation to the bands of the IB suspensions used as a
100% TsnC. Control was performed in the absence of additives; (B) thioredoxin
activity of TsnC refolded in the presence of the ﬁve additives that gave the highest
yields of soluble protein, in relation to TsnC obtained by puriﬁcation of the soluble
fraction of bacteria, used as a control of thioredoxin activity. Refolding buffer:
50 mM Tris–HCl, pH 8.0, 1 mM EDTA, and 0.75 M GdnHCl. Bars labeled ‘‘–GdnHCl’’
indicate that guanidine was not added to the reaction mixture. The samples were
pressurized in buffer containing a ﬁnal concentration of 10 mM redox pair (9 mM
GSH and 1 mM GSSG) at 2.4 kbar for 90 min and incubated for 16 h at 1 bar. The
supernatants were subjected to dialysis.
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been completely elucidated. However, it has been proposed that
this amino acid inhibits non-native hydrophobic interactions and
stabilizes denatured and partially folded proteins by interacting
with non-native exposed hydrophobic stretches, thereby diminish-
ing protein–protein interactions and aggregation [32–34].
Indeed, arginine is a very useful reagent for protein refolding at
atmospheric pressure or even at high pressure [35]. To test how
useful these types of reagents are, we compressed an IB suspension
in the presence of additives. The addition of 0.5 M arginine in buf-
fer which pH was not adjusted (11.0) in the presence or in the
absence of GdnHCl, buffer containing arg and adjusted to pH 8.0
in the presence of 0.75 M GdnHCl, 1 mM Triton X-100 and
0.5 mM Tween 20 were the conditions that best enhanced the TsnC
solubility as compared with the sample compressed in the absence
of additives (Fig. 4A). We assessed the TsnC enzymatic activity of
the protein that was subjected to compression and incubated in
buffers containing the ﬁve additives that enhanced the refolding
yields to the highest levels (Fig. 4B). TsnC obtained in the soluble
fraction of E. coli cultivated at 20 C (labeled as ‘‘Control TsnC’’)
served as control of TsnC with full biological activity. The protein
refolded in buffer containing 0.5 M arginine adjusted to pH 8.0 pre-
sented speciﬁc activity similar to the native protein, which indicate
that the presence of arginine enhanced the yield of obtainment of
soluble TsnC (Fig. 4A) with biological activity (Fig. 4B and Table 1).
In contrast, the sample refolded in buffer containing arginine at
high pH (11.0) exhibited markedly lower TsnC enzymatic activity,
in both the presence and absence of GdnHCl (Fig. 4B). The presence
of Tween 20 and Triton X-100 prompted smaller decrease in the
TsnC speciﬁc enzymatic activity.
TsnC IB
Puriﬁed recombinant IBs appear as spherical, ellipsoidal, or
cylindrical particles measuring between 0.5 and 1.8 mm, charac-
terized by a smooth and porous surface [36,37]. TsnC IBs consisted
of spherical particles (Fig. 5A). The particles present in the portion
of the TsnC suspension that remained in the insoluble fraction after
HHP treatment (Fig. 5B) emerged in lower quantity and were
smaller, probably as a result of partial solubilization upon HHP
or re-aggregation upon decompression.
Analysis of the secondary structure of refolded TsnC
The structure of E. coli thioredoxin presents ﬁve b-sheets
ﬂanked by four a-helices [38]. The circular dichroism spectrum
of the refolded X. fastidiosa TsnC in buffer containing 0.5 M arginine
adjusted to pH 8.0 and subsequently subjected to puriﬁcation was
typical of a regular secondary structure (Fig. 6). Remarkably, the
spectra of the refolded and Control TsnC were highly similar, an
additional indication that they present a resemblance of structure.
Conclusions
We optimized the GSH/GSSG ratio, GdnHCl concentration, type
of additives, and incubation at different pressure levels for refold-
ing of TsnC from IB dissociated at HHP (2.4 kbar). The solubilization
yields of HHP-treated IB reached a maximum around 2 M GdnHCl,
but enhanced thioredoxin activity occurred at 0.75 M GdnHCl. Sol-
ubilization yields varied little upon changing the GSH/GSSG ratio
from 9:1 to 1:9, but thioredoxin activity was strikingly higher in
Table 1
Speciﬁc activity of TsnC refolded in the presence of additives as compared with
Control TsnC.
Additive Speciﬁc activity (lM TNB.s-1.lM TsnC-1)
Control TsnC 0.374 ± 0.0334
Arg pH 8.0 0.383 ± 0.0119
Arg pH 11.0 0.078 ± 0.0054
Arg pH 11.0 – GdnHCl 0.127 ± 0.0040
Tween 20 0.247 ± 0.0094
Triton X-100 0.283 ± 0.0002
Fig. 5. Scanning electron microscopy of the insoluble aggregates. (A) TsnC IB; (B)
insoluble fraction of the IB suspension that remained after HHP. Gain of 8000. The
bar indicates a size of 2 lm.
Fig. 6. Analysis of the secondary structure of thioredoxin TsnC by circular
dichroism in comparison to TsnC used as control: soluble and bioactive TsnC
produced by transformed bacteria cultivated at 20 C, as described. The spectra
were recorded in 20 mM Tris–HCl, pH 8.0 in the range of 200–300 nm, and
expressed in terms of molar ellipticity [h]. Three measurements were taken to
obtain the average values.
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more reducing environments. The results showed that it is
advantageous to select the refolding conditions on the basis of both
the protein solubility and the biological activity. The following
conditions afforded high TsnC yield: application of HHP (2.4 kbar)
for 90 min to a suspension of IB containing non-denaturing levels
of GdnHCl (0.75 M), 0.5 M arginine at pH 8.0, and 10 mM redox
pair at a 9:1 GSH:GSSG ratio followed by incubation at 1 bar for
16 h. In the optimized conditions, the TsnC refolding process fur-
nished 81% yield of soluble and biologically active protein from
HHP-incubated IB. In the same buffer conditions, the yield of
refolding of TsnC from IB suspensions maintained at atmospheric
pressure was only 4.0%. The advantage of using the HHP-refolding
protocol is evidenced by the facts that the production of the TsnC
as insoluble IB by E. coli cultivated at 37 C is higher than the sol-
uble protein by bacteria cultivated at 20 C, summed to the high
refolding yield and the fact that the refolded protein presents a
strikingly lower contamination by E. coli proteins than the soluble
protein expressed at 20 C.
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